Abstract
BackgroundAssessment of inflammatory activity in patients with ulcerative colitis (UC) is crucial to the prediction of relapse. Confocal laser endomicroscopy (CLE) is an accurate tool for assessing inflammatory activity in UC patients. This study aimed to evaluate whether CLE could be used to predict UC relapse reliably.MethodsIn total, forty-three patients with documented UC were analyzed in this study. Patients identified as having obvious active inflammation by conventional colonoscopy were excluded. The mucosa of each patient’s sigmoid colon and rectum was assessed by CLE before targeted biopsies were taken. The patients were then followed up for at least 12 months to evaluate relapse according to the Simple Clinical Colitis Activity Index. The correlation between CLE classification and UC relapse was evaluated.ResultsSeventeen of 20 patients with histologically confirmed normal or chronic inflammation were diagnosed as having non-active inflammation by real-time CLE and 22 of 23 patients with histologically confirmed acute inflammation were diagnosed as having active inflammation by CLE. The sensitivity, specificity, and accuracy of CLE in real-time diagnosis of active inflammation were 95.7%, 85%, and 90.7%, respectively. The agreement between CLE and conventional histology was excellent (kappa value = 0.812). Two of 18 (11.1%) patients who were classified as having non-active inflammation by CLE relapsed, while 16 of 25 (64%) patients classified as having as active inflammation relapsed. The relapse rate of patients with active inflammation was significantly higher than of those with non-active inflammation (P < 0.001).ConclusionsCLE is comparable to conventional histology in predicting relapse in patients with UC.
Highlights
Assessment of inflammatory activity in patients with ulcerative colitis (UC) is crucial to the prediction of relapse
A recent study by Bessissow et al found that the presence of basal plasmacytosis and a Geboes Index (GI) score of ≥3.1 predicted relapse of UC with normal endoscopy [4]
Inclusion and exclusion criteria Patients with documented UC under colonoscopic surveillance from January 1 to June 31, 2011 were recruited into this study. Those fulfilling the criteria for clinical remission of UC according to the Simple Clinical Colitis Activity Index (SCCAI) were included [15]
Summary
Assessment of inflammatory activity in patients with ulcerative colitis (UC) is crucial to the prediction of relapse. This study aimed to evaluate whether CLE could be used to predict UC relapse reliably. Histological evidence currently suggests that active inflammation and basal plasmacytosis in colonic biopsies are the most reliable parameters for prediction of relapse [3]. A recent study by Bessissow et al found that the presence of basal plasmacytosis and a Geboes Index (GI) score of ≥3.1 predicted relapse of UC with normal endoscopy [4]. With this background, the term “mucosal healing” was introduced as the goal of UC treatment. As clinical symptoms and signs are not well correlated with histological mucosal healing, endoscopic assessment is crucial in the management of UC, secondary to gold standard histological assessment
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
